Plasma asparaginase activity and asparagine depletion in patients with acute lymphoblastic leukemia (ALL) treated with pegaspargase (SS-PEG E. coli L-asparaginase): Results from Children's Oncology Group (COG) study AALLO7P4.

被引：3
|
作者：
Schore, Reuven J.
Devidas, Meenakshi
Bleyer, Archie
Reaman, Gregory H.
Winick, Naomi J.
Loh, Mignon L.
Raetz, Elizabeth A.
Carroll, William L.
Hunger, Stephen
Angiolillo, Anne L.
机构：
[1] Childrens Natl Med Ctr, Washington, DC 20010 USA
[2] Univ Florida, Gainesville, FL USA
[3] St Charles Hosp, Bend, OR USA
[4] US FDA, Silver Spring, MD USA
[5] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[6] UC San Francisco, San Francisco, CA USA
[7] Univ Utah, Salt Lake City, UT USA
[8] NYU Langone Med Ctr, New York, NY USA
[9] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.10508
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10508
引用
收藏
页数：2
相关论文
共 23 条
  • [1] Plasma asparaginase activity and asparagine depletion in acute lymphoblastic leukemia patients treated with pegaspargase on Children's Oncology Group AALL07P4
    Schore, Reuven J.
    Devidas, Meenakshi
    Bleyer, Archie
    Reaman, Gregory H.
    Winick, Naomi
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Carroll, William L.
    Hunger, Stephen P.
    Angiolillo, Anne L.
    LEUKEMIA & LYMPHOMA, 2019, 60 (07) : 1740 - 1748
  • [2] An isocratic fluorescence HPLC assay for the monitoring of L-asparaginase activity and L-asparagine depletion in children receiving E. coli L-asparaginase for the treatment of acute lymphoblastic leukaemia
    Nath, Christa E.
    Dallapozza, Luciano
    Eslick, Adam E.
    Misra, Ashish
    Carr, Deborah
    Earl, John W.
    BIOMEDICAL CHROMATOGRAPHY, 2009, 23 (02) : 152 - 159
  • [3] Pharmacokinetic (PK) and pharmacodynamics (PD) properties of SC-PEG e. coli L-asparaginase (EZN-2285) in the treatment of patients with acute lymphoblastic leukemia ( ALL): Results from Children's Oncology Group (COG) study AALL07P4.
    Angiolillo, Anne L.
    Schore, Reuven J.
    Reaman, Gregory H.
    Winick, Naomi Joan
    Devidas, Meenakshi
    Zheng, Hao W.
    Wood, Charlotte
    Lane, Ashley R.
    Raetz, Elizabeth A.
    Carroll, William L.
    Hunger, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E-coli L-asparaginase as first exposure
    Rizzari, C
    Zucchetti, M
    Conter, V
    Diomede, L
    Bruno, A
    Gavazzi, L
    Paganini, M
    Sparano, P
    Lo Nigro, L
    Aricò, M
    Milani, M
    D'Incalci, M
    ANNALS OF ONCOLOGY, 2000, 11 (02) : 189 - 193
  • [5] ADMINISTRATION OF ERWINIA ASPARAGINASE FOLLOWING ALLERGY TO PEG-ASPARAGINASE IN CHILDREN AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA ACHIEVES THERAPEUTIC NADIR SERUM ASPARAGINASE ACTIVITY: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP (COG)
    Salzer, Wanda
    Asselin, Barbara
    Supko, Jeffrey
    Devidas, Meenakshi
    Kaiser, Nicole
    Plourde, Paul
    Winick, Naomi
    Reaman, Gregory
    Raetz, Elizabeth
    Carroll, William
    Hunger, Stephen
    PEDIATRIC BLOOD & CANCER, 2011, 56 (06) : 922 - 922
  • [6] Failure of asparagine (ASN) depletion, not inadequate asparaginase (ASNase) activity, predicts relapse in standard risk (SR) childhood acute lymphoblastic leukemia (ALL): A Children's Oncology Group (COG) report
    Avramis, Vassilios I.
    Holcenberg, John S.
    Ettinger, Alice G.
    Stork, Linda C.
    La, Mei
    Gaynon, Paul S.
    BLOOD, 2007, 110 (11) : 181A - 181A
  • [7] Pharmacokinetic and Pharmacodynamic Properties of Calaspargase Pegol Escherichia coli L-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Study AALL07P4
    Angiolillo, Anne L.
    Schore, Reuven J.
    Devidas, Meenakshi
    Borowitz, Michael J.
    Carroll, Andrew J.
    Gastier-Foster, Julie M.
    Heerema, Nyla A.
    Keilani, Taha
    Lane, Ashley R.
    Loh, Mignon L.
    Reaman, Gregory H.
    Adamson, Peter C.
    Wood, Brent
    Wood, Charlotte
    Zheng, Hao W.
    Raetz, Elizabeth A.
    Winick, Naomi J.
    Carroll, William L.
    Hunger, Stephen P.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (34) : 3874 - U276
  • [8] Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group
    Rau, Rachel E.
    Dreyer, ZoAnn
    Choi, Mi Rim
    Liang, Wei
    Skowronski, Roman
    Allamneni, Krishna P.
    Devidas, Meenakshi
    Raetz, Elizabeth A.
    Adamson, Peter C.
    Blaney, Susan M.
    Loh, Mignon L.
    Hunger, Stephen P.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (03)
  • [9] Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse:: A children's oncology group study (CCG-1941)
    Jarrar, Mohammad
    Gaynon, Paul S.
    Periclou, Antonia P.
    Fu, Cecilia
    Harris, Richard E.
    Stram, Daniel
    Altman, Arnold
    Ostrom, Bruce
    Breneman, John
    Steele, David
    Trigg, Michael
    Zipf, Theodore
    Avramis, Vassilios I.
    PEDIATRIC BLOOD & CANCER, 2006, 47 (02) : 141 - 146
  • [10] Administration of Erwinia Asparaginase (Erwinase®) Following Allergy to PEG-Asparaginase In Children and Young Adults with Acute Lymphoblastic Leukemia Treated on AALL07P2 Achieves Therapeutic Nadir Serum Asparaginase Activity: A Report From the Children's Oncology Group (COG).
    Salzer, Wanda
    Asselin, Barbara
    Supko, Jeffrey
    Devidas, Meenakshi
    Kaiser, Nicole
    Plourde, Paul V.
    Winick, Naomi
    Reaman, Gregory
    Raetz, Elizabeth
    Carroll, William L.
    Hunger, Stephen
    BLOOD, 2010, 116 (21) : 882 - 882
123